Monthly Archives: December 2013

Biothera to Present Non-Small Cell Lung Cancer Study Data at Upcoming AACR/IASLC Conference

EAGAN, MN — December 12, 2013 — Biothera announced today the acceptance of a poster presentation on the results of its Phase 2b clinical trial in non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer to be held Jan. 6-9 in San Diego....

Read More


Biothera Broadens Understanding of Biomarker for Cancer Immunotherapy Imprime PGG

EAGAN, MN – December 5, 2013 – Biothera researchers have broadened their understanding of a biomarker that may enable doctors to predict which cancer patients will best respond to Imprime PGG®, the company’s immunotherapy in Phase 3 drug development for colorectal cancer. The new findings will be presented today at the VIC Congress – Vaccines, Immunotherapies and Cell Therapies, in Brussels. The level of a...

Read More